Raymonde Busch
Impact in
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 70
- Chronic Lymphocytic Leukemia Research 67
-
- Lymphoma Diagnosis and Treatment 48
- Co-authors
- Michael HallekKaren BeckerU. FinkHeinz HöflerKatja OttWerner KisslingStephan StilgenbauerK. Böttcher
- Journals
- Blood (47 papers)Journal of Clinical Oncology (8 papers)Cancer (8 papers)British Journal of Haematology (4 papers)Radiotherapy and Oncology (4 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Raymonde Busch
169 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Genetics 3.0k
- Pathology and Forensic Medicine 2.6k
- Gastroenterology 771
- Pulmonary and Respiratory Medicine 3.5k
- Oncology 2.0k
Countries citing papers authored by Raymonde Busch
This map shows the geographic impact of Raymonde Busch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymonde Busch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymonde Busch more than expected).
Fields of papers citing papers by Raymonde Busch
This network shows the impact of papers produced by Raymonde Busch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymonde Busch. The network helps show where Raymonde Busch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raymonde Busch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 1 | |
| 2 | 2009 | 238 | |
| 3 | 2009 | 115 | |
| 4 | 2009 | 74 | |
| 5 | 2008 | 67 | |
| 6 | 2007 | 31 | |
| 7 | 2007 | 100 | |
| 8 | 2006 | 31 | |
| 9 | 2006 | 27 | |
| 10 | 2006 | 8 | |
| 11 | 2005 | 55 | |
| 12 | 2005 | 5 | |
| 13 | 2004 | 31 | |
| 14 | 2004 | 68 | |
| 15 | Fludarabine induces higher response rates in first line therapy of older patients with advanced chronic lymphocytic leukemia than chlorambucil Interim analysis of a phase III study of the German CLL Study Group | 2003 | 9 |
| 16 | 2003 | 51 | |
| 17 | Fludarabine, Mitoxantrone and Cyclophosphamide Combination Therapy in Relapsed Chronic Lymphocytic Leukemia with or without G-CSF Results of the First Interim Ananlysis of a Phase III Study of the German CLL Study Group | 2002 | 3 |
| 18 | 1999 | 2 | |
| 19 | 1997 | 58 | |
| 20 | 1992 | 28 |
About Raymonde Busch
Raymonde Busch is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 169 papers that have together received 9.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (67 papers), Lymphoma Diagnosis and Treatment (48 papers), Immunodeficiency and Autoimmune Disorders (37 papers), Acute Lymphoblastic Leukemia research (20 papers), Gastric Cancer Management and Outcomes (15 papers), Advanced Breast Cancer Therapies (10 papers), Esophageal Cancer Research and Treatment (10 papers) and Congenital Heart Disease Studies (9 papers). The work is most often cited by research in Genetics (3.0k citations), Pathology and Forensic Medicine (2.6k citations), Gastroenterology (771 citations), Pulmonary and Respiratory Medicine (3.5k citations) and Oncology (2.0k citations). Raymonde Busch has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Michael Hallek, Karen Becker, U. Fink, Heinz Höfler, Katja Ott, Werner Kissling, Stephan Stilgenbauer, K. Böttcher, Stefan Leucht and Hartmut Döhner. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, British Journal of Haematology and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.